All News
For Some Measles Patients, Vitamin A Remedy Supported by RFK Jr. Leaves Them More Ill
After the health secretary promoted vitamin A as a cure, parents in West Texas began giving their children high doses, sometimes to prevent infection.
Read MoreSenate Committee Backs Dr. Oz for CMS Administrator
(MedPage Today) -- The Senate Finance Committee voted 14-13 along party lines Tuesday to recommend that Mehmet Oz, MD, MBA, be confirmed as Centers for Medicare & Medicaid Services (CMS) administ
Read MoreSurprising Findings From New Research About Dementia and Marriage
(MedPage Today) -- Unmarried people had a lower risk of dementia than those who were married, data from an 18-year cohort study of 24,000 older adults suggested.
Read MoreOpinion: 23andMe’s bankruptcy doesn’t diminish its impact
“23andMe might have filed for bankruptcy, but the transformation it brought to health care over nearly two decades is irreversible,” writes @michaelmina_lab.
Read MoreSTAT+: Oz moves closer to role running Medicare, Medicaid on party-line vote
Dr. Oz, a former heart surgeon and TV host, is closer to becoming CMS administrator after clearing a key Senate committee vote.
Read MoreHorace Hale Harvey III, Early Abortion Rights Advocate, Dies at 93
A religious organization recruited him to help open New York City’s first independent abortion clinic, though it was unaware that Louisiana had taken away his license.
Read MoreRoutine Urodynamics Fails to Improve Overactive Bladder Beyond Clinical Evaluation
(MedPage Today) -- Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with comprehensive clinical assessment (CCA), a large randomi
Read More5 High-Level CDC Officials Are Leaving in the Latest Turmoil for the Agency
(MedPage Today) -- The CDC was rocked by five high-level departures on Tuesday in the latest turmoil for the nation's top public health agency.
Read MoreFDA OKs New Option for Uncomplicated UTIs in Women, Girls
(MedPage Today) -- The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 years and up, GSK announced on Tuesday.
Read MoreWhat Does the Science Say About Cell Phones and Cancer?
(MedPage Today) -- In an interview with "Fox & Friends" last week, HHS Secretary Robert F. Kennedy Jr.
Read More